On this page: About the National Data | Methodology | History
About the National Data
Data
Baseline: 2.9 percent of the population aged 15 to 24 years had serologic evidence of HSV-2 during 2013-16
Target: 2.9 percent
Numerator
Estimated number of persons aged 15 to 24 years with serologic evidence of herpes simplex virus type 2 (HSV-2) infection.
Denominator
Number of persons aged 15 to 24 years.
Target-setting method
Maintain the baseline
Target-setting method justification
This method was used because the Healthy People 2030 Workgroup Subject Matter Experts did not anticipate that the linear trend will continue and expected minimal improvement in the next decade. Maintaining the baseline is the desired target because there are limited evidence-based interventions to favorably impact the trend.
Methodology
Methodology notes
This measure tracks the estimated proportion of persons aged 15 to 24 years with serologic evidence of HSV-2 infection, as measured by NHANES, a national probability survey.
History
Comparable HP2020 objective
Modified, which includes core objectives that are continuing from Healthy People 2020 but underwent a change in measurement.
Changes between HP2020 and HP2030
This objective differs from Healthy People 2020 objective STD-10 in that objective STD-10 tracked persons aged 20 to 29 years with herpes Simplex virus-2 (HSV-2), while this objective tracks persons aged 15 to 24 years (the age group at greatest risk for new infections) with HSV-2.
